» Articles » PMID: 23649880

Institutional Review Board Barriers and Solutions Encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a National Multicenter Practice-based Implementation Trial

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2013 May 8
PMID 23649880
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To categorize institutional review board (IRB) challenges and solutions encountered in a multicenter practice-based research network (PBRN) study and to assess the impact of IRB requirements on the willingness of individual principal investigators (PIs) to participate in future PBRN studies.

Design: Descriptive analysis of IRB challenges and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial, a multicenter prospective cluster-randomized study conducted by the National Interdisciplinary Primary Care PBRN, and a correlational analysis from a survey of individual site PIs.

Measurements And Main Results: IRB barriers encountered and solutions were categorized for study sites. A survey of study-site PIs was conducted with a correlational analysis assessing the impact of various IRB requirements and the willingness of individual PIs to participate in future PBRN studies; of 31 study sites participating in the CAPTION study, 28 study-site PIs were surveyed. IRBs posed a number of challenges including bias regarding the source of the application, issues regarding study design, study instruments, access to patient records, study procedures, Spanish-only speaking subjects, role of clinic physicians, interdepartmental concerns, and updates at continuing review. Responses from the PI survey (21 of 28 PIs surveyed [75% response rate]) indicated that the willingness of an individual to serve as a PI in the future was inversely related to the perceived difficulty of obtaining initial (rS  = -0.599, p=0.004) and continuing (rS  = -0.464, p=0.034) IRB approval.

Conclusion: Significant time and resources were required to address various challenges associated with IRB approval, which had a negative impact on an individual PI's willingness to participate in future PBRN projects. A revision of current rules and regulations regarding the protection of human subjects for practice-based studies, improvement in IRB processes, and support from coordinating centers may decrease the burden associated with IRB approval and increase participation in practice-based research.

Citing Articles

A cross-sectional examination of the profile of chiropractors recruited to the Australian Chiropractic Research Network (ACORN): a sustainable resource for future chiropractic research.

Adams J, Peng W, Steel A, Lauche R, Moore C, Amorin-Woods L BMJ Open. 2017; 7(9):e015830.

PMID: 28965091 PMC: 5640145. DOI: 10.1136/bmjopen-2017-015830.


Engaging in Collaborative Research: Focus on the Pharmacy Practitioner.

Badowski M, Mazur J, Lam S, Miyares M, Schulz L, Michienzi S Hosp Pharm. 2017; 52(1):33-43.

PMID: 28179739 PMC: 5278912. DOI: 10.1310/hpj5201-33.


Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.

Carter B, Ardery G J Am Heart Assoc. 2016; 5(12).

PMID: 27993832 PMC: 5210445. DOI: 10.1161/JAHA.116.004432.


Sharing big biomedical data.

Toga A, Dinov I J Big Data. 2016; 2.

PMID: 26929900 PMC: 4768816. DOI: 10.1186/s40537-015-0016-1.


Cluster randomized trials for pharmacy practice research.

Gums T, Carter B, Foster E Int J Clin Pharm. 2015; 38(3):607-14.

PMID: 26715549 DOI: 10.1007/s11096-015-0205-1.


References
1.
Bakken S, Lantigua R, Busacca L, Thomas Bigger J . Barriers, enablers, and incentives for research participation: a report from the Ambulatory Care Research Network (ACRN). J Am Board Fam Med. 2009; 22(4):436-45. PMC: 2744643. DOI: 10.3122/jabfm.2009.04.090017. View

2.
Stair T, Reed C, Radeos M, Koski G, Camargo C . Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med. 2001; 8(6):636-41. DOI: 10.1111/j.1553-2712.2001.tb00177.x. View

3.
Petersen L, Simpson K, SoRelle R, Urech T, Chitwood S . How variability in the institutional review board review process affects minimal-risk multisite health services research. Ann Intern Med. 2012; 156(10):728-35. PMC: 4174365. DOI: 10.7326/0003-4819-156-10-201205150-00011. View

4.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72. DOI: 10.1001/jama.289.19.2560. View

5.
Hirshon J, Krugman S, Witting M, Furuno J, Rhona Limcangco M, Perisse A . Variability in institutional review board assessment of minimal-risk research. Acad Emerg Med. 2002; 9(12):1417-20. DOI: 10.1111/j.1553-2712.2002.tb01612.x. View